BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 24676432)

  • 1. The neurofibromatosis: which one and why?
    Riccardi VM
    Arq Neuropsiquiatr; 2014 Mar; 72(3):177-8. PubMed ID: 24676432
    [No Abstract]   [Full Text] [Related]  

  • 2. Painless cutaneous nodules.
    Khodaee M
    J Fam Pract; 2012 Aug; 61(8):489-91. PubMed ID: 22871659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurofibromatoses: part 1 - diagnosis and differential diagnosis.
    Rodrigues LO; Batista PB; Goloni-Bertollo EM; de Souza-Costa D; Eliam L; Eliam M; Cunha KS; Darrigo-Junior LG; Ferraz-Filho JR; Geller M; Gianordoli-Nascimento IF; Madeira LG; Malloy-Diniz LF; Mendes HM; de Miranda DM; Pavarino EC; Baptista-Pereira L; Rezende NA; Rodrigues Lde O; da Silva CM; de Souza JF; de Souza ML; Stangherlin A; Valadares ER; Vidigal PV
    Arq Neuropsiquiatr; 2014 Mar; 72(3):241-50. PubMed ID: 24676443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurofibromatosis: part 2--clinical management.
    Batista PB; Bertollo EM; Costa Dde S; Eliam L; Cunha KS; Cunha-Melo JR; Darrigo Junior LG; Geller M; Gianordoli-Nascimento IF; Madeira LG; Mendes HM; Miranda DM; Mata-Machado NA; Morato EG; Pavarino ÉC; Pereira LB; Rezende NA; Rodrigues Lde O; Sette JB
    Arq Neuropsiquiatr; 2015 Jun; 73(6):531-43. PubMed ID: 26083891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple cutaneous plexiform schwannomas. Report of a case and review of the literature with particular reference to the association with types 1 and 2 neurofibromatosis and schwannomatosis.
    Reith JD; Goldblum JR
    Arch Pathol Lab Med; 1996 Apr; 120(4):399-401. PubMed ID: 8619756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative assessment of whole-body tumor burden in adult patients with neurofibromatosis.
    Plotkin SR; Bredella MA; Cai W; Kassarjian A; Harris GJ; Esparza S; Merker VL; Munn LL; Muzikansky A; Askenazi M; Nguyen R; Wenzel R; Mautner VF
    PLoS One; 2012; 7(4):e35711. PubMed ID: 22558206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurofibromatosis.
    McClatchey AI
    Annu Rev Pathol; 2007; 2():191-216. PubMed ID: 18039098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Polyneuropathy associated with neurofibromatosis].
    Drouet A; Créange A
    Rev Neurol (Paris); 2005 Mar; 161(3):275-83. PubMed ID: 15800448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing the sensitivity of linear and volumetric MRI measurements to detect changes in the size of vestibular schwannomas in patients with neurofibromatosis type 2 on bevacizumab treatment.
    Morris KA; Parry A; Pretorius PM
    Br J Radiol; 2016 Sep; 89(1065):20160110. PubMed ID: 27452262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skin markers of malignancy.
    Trattner A
    J Am Acad Dermatol; 1994 Apr; 30(4):674-5. PubMed ID: 8157807
    [No Abstract]   [Full Text] [Related]  

  • 11. Metaplasia in a nerve-sheath sarcoma in Von Recklinghausen's disease.
    PAYNE RA
    Br J Surg; 1960 May; 47():688-90. PubMed ID: 14431161
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical features of spinal schwannomas in 65 patients with schwannomatosis compared with 831 with solitary schwannomas and 102 with neurofibromatosis Type 2: a retrospective study at a single institution.
    Li P; Zhao F; Zhang J; Wang Z; Wang X; Wang B; Yang Z; Yang J; Gao Z; Liu P
    J Neurosurg Spine; 2016 Jan; 24(1):145-54. PubMed ID: 26407091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging Evaluation of Plexiform Neurofibromas in Neurofibromatosis Type 1: A Survey-Based Assessment.
    Ahlawat S; Ly KI; Fayad LM; Fisher MJ; Lessing AJ; Berg DJ; Salamon JM; Mautner VF; Babovic-Vuksanovic D; Dombi E; Harris G; Plotkin SR; Blakeley J;
    Neurology; 2021 Aug; 97(7 Suppl 1):S111-S119. PubMed ID: 34230200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurofibromatosis.
    Roos KL; Muckway M
    Dermatol Clin; 1995 Jan; 13(1):105-11. PubMed ID: 7712636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recommendations for the collection and annotation of biosamples for analysis of biomarkers in neurofibromatosis and schwannomatosis clinical trials.
    Sundby RT; Rhodes SD; Komlodi-Pasztor E; Sarnoff H; Grasso V; Upadhyaya M; Kim A; Evans DG; Blakeley JO; Hanemann CO; Bettegowda C
    Clin Trials; 2024 Feb; 21(1):40-50. PubMed ID: 37904489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous plexiform schwannoma of the finger not associated with neurofibromatosis.
    Punia RS; Dhingra N; Mohan H
    Am J Clin Dermatol; 2008; 9(2):129-31. PubMed ID: 18284268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hybrid neurofibroma/schwannoma in neurofibromatosis type I exhibiting high FDG uptake in PET imaging.
    Yamasaki O; Akiyama M; Ichimura K; Yamaguchi M; Shiomi M; Iwatsuki K
    Eur J Dermatol; 2015 Apr; 25(2):181-2. PubMed ID: 25547895
    [No Abstract]   [Full Text] [Related]  

  • 18. Hybrid neurofibroma/schwannoma is overrepresented among schwannomatosis and neurofibromatosis patients.
    Harder A; Wesemann M; Hagel C; Schittenhelm J; Fischer S; Tatagiba M; Nagel C; Jeibmann A; Bohring A; Mautner VF; Paulus W
    Am J Surg Pathol; 2012 May; 36(5):702-9. PubMed ID: 22446939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant schwannoma: a frequent evolution of von Recklinghausen's disease.
    Risio M; Coverlizza S; Digirolamo P; Leli R; Saccia A
    Panminerva Med; 1987; 29(4):283-8. PubMed ID: 2963252
    [No Abstract]   [Full Text] [Related]  

  • 20. Neurofibromatosis and Schwannomatosis.
    Plotkin SR; Wick A
    Semin Neurol; 2018 Feb; 38(1):73-85. PubMed ID: 29548054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.